non-addictive

Translations

non-addictive

[ˈnɒnəˈdɪktɪv] ADJque no crea dependencia
References in periodicals archive ?
- September 5, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to welcome Tara Conner to the Company's Ambassador Board.
It is well-accepted that patients with these conditions would benefit greatly from an effective, non-addictive, GI-sparing anti-inflammatory/analgesic agent such as ATB-346.
NBA Hall of Famer Gary "The Glove" Payton has launched his own cannabis product line, CannaSports, seeking to provide a solution for athletes seeking safe, effective and non-addictive pain medication.
ATB-352, the second drug in Antibe's pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a gastrointestinal-safe derivative of aspirin.
Reducing nicotine levels in cigarettes to non-addictive levels is one of several possible ways to reduce smoking, according to the 2014 U.S.
The company aims to support the US FDA in implementing a new Agency rule requiring that all cigarettes sold in the US contain only minimally or non-addictive levels of nicotine; obtain a Modified Risk Tobacco Product (MRTP) marketing order from the FDA for the VLNC cigarettes; launch its proprietary VLNC cigarettes in the US and internationally; develop its hemp/cannabis intellectual property portfolio; and expand its presence in the hemp/cannabis industry.
Morgan Stanley's Richard Taylor and Sanath Sudarsan highlighted the US Food & Drug Administration is likely to publish a proposed rule on maximum nicotine in October, aiming to reduce nicotine in cigarettes to non-addictive or minimally addictive levels.
INDIANAPOLIS, May 28, 2019 /PRNewswire/--Eli Lilly and Company (NYSE: LLY) today announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain.
Eli Lilly and Company announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain.
Prismic Pharmaceuticals is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilising micro-palmitoylethanolamide's (PEA) entourage effect on certain drugs impacting the endocannabinoid system.
Full browser ?